Research into the genomes of malaria parasites opens the door to more potent, novel therapies.
Healthcare & Pharmaceuticals
A twice-yearly injection of Lenacapavir, however, offers a 96% lower risk of infection overall.
It is anticipated that this novel approach to creating ionizable lipids will have significant effects on mRNA-based vaccines and treatments, which are positioned to address a variety of illnesses, including infectious diseases and genetic abnormalities.
A team of researchers from Kyushu University has created a novel antibody that targets and inhibits the malfunction of the protein hepatocyte growth factor, or HGF, which is essential for developing, regenerating, and repairing skeletal muscle.
A class of tumors known as soft tissue sarcoma of the extremities develops in the muscles, tendons, fat, blood vessels, or nerves of the arms and leg
In 2022–2023, the researchers found people diagnosed with obesity without diabetes using a nationwide sample of medical insurance claims data from over 17 million persons with private insurance.
The active ingredient in the diabetes and weight-loss medications Wegovy and Ozempic is semaglutide, a glucagon-like peptide receptor (GLP-1R) molecule that reduces appetite and aids in blood sugar regulation in type 2 diabetes.
Teri Boudreaux is thankful for the time she gets to spend with her family, whether it’s hiking, playing with her grandkids, travelling with her spouse, lounging on the beach, or taking up new interests like pickleball. She has survived breast cancer twice. In spite of everything, though, she still harbours […]
C. difficile vaccine protected against C. difficile first-time infections and relapsing infections in animal models by eliciting a strong immune response, facilitating the removal of pre-existing C. diff bacteria from the gut
The outcomes of an international Phase III clinical trial conducted by researchers from the University of Pennsylvania Perelman School of Medicine and a multicenter group of investigators, published in the New England Journal of Medicine, show that adults with haemophilia B experienced an average 71% reduction in the number of […]
